Moreover, mutations in the human SLC39A14 gene have been suggested to affect Mn transport primarily in hepatocytes, thereby underlying the parkinsonism dystonia seen in patients with such mutations; data obtained with a transgenic zebrafish model appear to support this notion [4]. The gene discussed is SLC39A14; the disease is Parkinson disease.